{
    "code": 0,
    "data": [
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Change in Senior Management Personnel - Resignation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=666736f0-f1fa-4361-af25-6fcb2aafed97.pdf",
            "news_date": "2026-02-07 14:14:45"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Change in Senior Management Personnel - Resignation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2187f82-c73b-4571-a287-914f0d36060c.pdf",
            "news_date": "2026-02-05 21:57:28"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date",
            "news_body": "Intimation of Record Date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0683ebad-9b1b-4267-b08a-ade9f2012b66.pdf",
            "news_date": "2026-02-05 19:24:21"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors",
            "news_body": "Outcome of meeting of the Board of Directors- Declaration of Interim Dividend and Appointment of CFO",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d30dc0a8-c54c-453b-86c9-edb5acdfefb3.pdf",
            "news_date": "2026-02-05 19:14:40"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Change In Key Managerial Personnel - Letter Of Resignation",
            "news_body": "Change in Key Managerial Personnel- Letter of Resignation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5e78eec-b15e-4904-b0dc-fdc0d2c61e11.pdf",
            "news_date": "2026-02-05 18:58:08"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Shifting Of Registered Office",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements Regulations) 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b9939d5-3e23-4b73-98b6-222f08924ad0.pdf",
            "news_date": "2026-02-04 23:17:29"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve This is to intimate you that meeting of the Board of Directors of the Company will be held on February 5 2026 inter alia to consider declaration of Interim dividend if any for the financial year 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be9e59b7-fb2b-4d05-a2bb-4f35b7d2d4c0.pdf",
            "news_date": "2026-02-02 17:13:25"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of equity shares on exercise of Stock Options pursuant to the Employee Stock Option Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8232ac5-9e01-4b7d-9e2c-5bfd8b1eef4d.pdf",
            "news_date": "2026-01-30 18:15:58"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Key Managerial Personnel- Resignation of Chief Financial Officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7937f7b-aae4-40bc-befe-901aab2e65e3.pdf",
            "news_date": "2026-01-29 15:37:02"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Torrent Pharmaceuticals Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E712E584_25E0_426E_8B1F_229094C911A2_145016.pdf",
            "news_date": "2026-01-24 14:50:22"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 23 2026 for Tau Investment Holdings Pte. Ltd.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51B86AAD_ABCA_4DA2_9308_360A992F2F84_114028.pdf",
            "news_date": "2026-01-24 11:41:39"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Torrent Pharmaceuticals Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=016FF41C_D21A_4BC2_B08D_CDAD6E292E8E_082828.pdf",
            "news_date": "2026-01-22 08:28:32"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tau Investment Holdings Pte Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94755156_7831_4320_9ABB_6537AC97CEF8_082622.pdf",
            "news_date": "2026-01-22 08:26:27"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f933b2d5-150c-4acd-9e0e-334d984e7e57.pdf",
            "news_date": "2026-01-21 21:57:20"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendum To The Outcome Of The First Board Meeting Held On 21 January 2026",
            "news_body": "Corrigendum",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19384bb5-f57b-4c45-9e32-78492675c925.pdf",
            "news_date": "2026-01-21 21:11:02"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 31A(10)(Ii) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations\").",
            "news_body": "Disclosure under Regulation 31A of LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b51bb625-029a-4063-ac6a-cbf99e72f8be.pdf",
            "news_date": "2026-01-21 15:45:13"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Change in Directors-Appointment of Directors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0428e00d-a42c-45c6-bda4-c2a93c3385bb.pdf",
            "news_date": "2026-01-21 14:58:03"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 21 January 2026",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e40d258e-90fa-48f7-b005-dd00e9afed18.pdf",
            "news_date": "2026-01-21 14:32:00"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of ESOPs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcd2a559-dd31-4ff1-96b2-960db18f7e27.pdf",
            "news_date": "2026-01-21 14:01:33"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "6aa97559-4810-46b9-b6b1-77a656b79619",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42edf473-5fa8-4e9f-8f66-e0a26bd8ae38.pdf",
            "news_date": "2026-01-19 16:33:50",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42edf473-5fa8-4e9f-8f66-e0a26bd8ae38.pdf",
            "news_date": "2026-01-19 16:33:50"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement pertaining to financial results for the quarter and nine months ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d02c4a94-a571-4d92-ad41-07ec4c6e19a9.pdf",
            "news_date": "2026-01-17 17:42:46"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "a817c8cb-fb67-4fad-967b-4a9915172e58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca617db8-1cc0-4ddc-b545-f22a5147da9a.pdf",
            "news_date": "2026-01-16 18:19:21",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca617db8-1cc0-4ddc-b545-f22a5147da9a.pdf",
            "news_date": "2026-01-16 18:19:21"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abaec7fd-5964-4fba-b8f6-2818537876b9.pdf",
            "news_date": "2026-01-16 18:13:05"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors",
            "news_body": "Outcome of meeting of Board of Directors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a75f5a07-03af-462d-90bd-1cdfb8bce55d.pdf",
            "news_date": "2026-01-16 18:10:50"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Additional Investment in wholly-owned subsidiary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9390c824-316f-4e62-bfc3-1bc4d69c9c94.pdf",
            "news_date": "2026-01-07 14:49:04"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliances- Certificate under Reg.74 (5) of SEBI (DP) Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3391606f-4e9a-45a5-8053-387573da7e79.pdf",
            "news_date": "2026-01-06 18:23:25"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investors/Analysts call with Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3310d577-3dc1-4c35-9d45-cfc723f205fd.pdf",
            "news_date": "2026-01-05 16:05:13"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Order",
            "news_body": "Receipt of Order",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56bf1b16-6150-4f8f-88ef-9e0ec4519674.pdf",
            "news_date": "2025-12-30 15:21:07"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ending On December 31 2025",
            "news_body": "JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2026 inter alia to consider and approve the unaudited financial results for the quarter and nine months ending on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85f524ef-0147-4d1b-bb16-f3fb9f2cd140.pdf",
            "news_date": "2025-12-29 18:46:20"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window closure period",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32568f6b-1b73-4ac7-a7b0-95f3e2457475.pdf",
            "news_date": "2025-12-29 18:42:42"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Receipt of Order",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e318e1-9dc5-4550-9e88-b5165f660bed.pdf",
            "news_date": "2025-12-24 17:19:18"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "DJSI (Dow Jones Sustainable Index) ESG Score Release",
            "news_body": "DJSI (Dow Jones Sustainable Index) ESG Score Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8532d0-0b87-40c6-990a-83ddf0c428fe.pdf",
            "news_date": "2025-12-22 18:55:26"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of Order",
            "news_body": "Receipt of order from the Joint Commissioner of State Tax Uttar Pradesh",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=864dfa2c-9e27-444c-8c46-c543f814eed3.pdf",
            "news_date": "2025-12-16 13:38:05"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Open Offer",
            "caption": "Updates on Open Offer",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Post Offer Advertisement under Regulations 18(12) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended (SEBI (SAST) Regulations) for the attention of the eligible Shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").<BR>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4B454C9E-976A-4C25-8BB3-0184D3D8211D-084940.pdf",
            "news_date": "2025-12-09 08:49:52"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares on exercise of stock options pursuant to ESOP Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7343470-b9b9-4214-93e0-46290bb78b84.pdf",
            "news_date": "2025-12-06 15:06:54"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares on exercise of stock options pursuant to Employee Stock Option Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2428873a-83a9-4664-b736-f3b91e6e89cb.pdf",
            "news_date": "2025-11-23 18:58:17"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Open Offer",
            "caption": "Updates on Open Offer",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Offer Opening Advertisement under Regulations 18(7) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended (\"SEBI (SAST) Regulations\") and Corrigendum to the Detailed Public Statement for the attention of the eligible Shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6BA6F2C7-B868-47B3-A85F-22BEBBC40AF2-183027.pdf",
            "news_date": "2025-11-17 18:30:39"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Investors/Analysts call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc2db954-76c9-466a-8dc5-2db0027ac5e5.pdf",
            "news_date": "2025-11-14 18:25:01"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d03f63a6-e5e3-4636-b711-33a1e62438b3.pdf",
            "news_date": "2025-11-14 18:21:05"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement pertaining to Recommendations of the Committee of Independent Directors on the Open Offer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fb94d36-6c4b-491b-831b-f3e7bcf26bf6.pdf",
            "news_date": "2025-11-12 18:16:46"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "7d423e3e-132f-4207-932a-03ec40de1cf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a70ee3a-7834-4a64-861e-5510ce157d8e.pdf",
            "news_date": "2025-11-12 17:57:37",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a70ee3a-7834-4a64-861e-5510ce157d8e.pdf",
            "news_date": "2025-11-12 17:57:37"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement pertaining to financial results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce27d297-717a-4d27-b963-b3d396881392.pdf",
            "news_date": "2025-11-12 13:40:06"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "5f7e6c3c-a69c-48f4-a412-893529356ef8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9c335f8-6bfd-42f9-9fe5-42d6804ef0a1.pdf",
            "news_date": "2025-11-11 17:09:23",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9c335f8-6bfd-42f9-9fe5-42d6804ef0a1.pdf",
            "news_date": "2025-11-11 17:09:23"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baf1e7b7-699b-4276-a92b-55671be11baf.pdf",
            "news_date": "2025-11-11 17:05:59"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of meeting of Board of Directors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49662177-187c-41a1-9040-57ae55be6fab.pdf",
            "news_date": "2025-11-11 17:00:31"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Letter of Offer",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Letter of Offer for the attention of the eligible shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7C0F4A59-2F98-459E-9241-3040CA212B06-083505.pdf",
            "news_date": "2025-11-07 08:35:19"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication regarding shifting of registered office of the Company from Maharashtra to Gujarat",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fda803d-901f-45bb-8380-95a76a2642dd.pdf",
            "news_date": "2025-10-31 17:12:18"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Update on Investors/analysts call with management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=883b9703-1b88-40c2-82a6-a484413dc76b.pdf",
            "news_date": "2025-10-31 14:42:02"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication regarding change in Registered Office",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98b721a0-acc9-4af9-8120-12bc27419e7e.pdf",
            "news_date": "2025-10-31 14:08:51"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "4Th Sustainability (ESG) Report",
            "news_body": "4th Sustainability (ESG) Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b931c1a-0d0a-4c56-ac59-71f8705c1c1c.pdf",
            "news_date": "2025-10-24 16:14:18"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investors/analysts call with management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d109f6e-fe78-43c0-9f66-9e6803646d50.pdf",
            "news_date": "2025-10-24 15:34:07"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025.",
            "news_body": "JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the unaudited financial results for the quarter and half year ended on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbfbe894-b1f9-44d9-8efb-a96d204208e5.pdf",
            "news_date": "2025-10-24 11:11:15"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg.74 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3db26c1f-6f1a-49e6-96ea-02e550402547.pdf",
            "news_date": "2025-10-08 16:51:06"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window closure period",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69c272c8-1f2c-4f2f-a264-00c66018a0d6.pdf",
            "news_date": "2025-09-30 14:07:26"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Receipt of Order",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee1f101d-6ff6-463d-b1a4-d4aab849f23b.pdf",
            "news_date": "2025-09-08 17:40:31"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Open Offer",
            "caption": "Updates on Open Offer",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Corrigendum to the Public Announcement Detailed Public Statement and the Draft Letter of Offer for the attention of the eligible shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4E0A218F-FBB8-4F4D-9130-261745064D9A-164118.pdf",
            "news_date": "2025-09-04 16:41:22"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of equity shares on exercise of stock options pursuant to employee stock option scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1f009c0-0a53-4c7f-9db0-28a270133b45.pdf",
            "news_date": "2025-09-01 18:39:13"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Cessation of Non-Executive Independent Director upon completion of term",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cf37001-823b-4f24-80fd-54354b61d160.pdf",
            "news_date": "2025-08-31 11:08:36"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ee7439b-b173-438c-9b4f-15befdb1495d.pdf",
            "news_date": "2025-08-14 13:39:12"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a6c10d9-4ad5-4160-9f62-8fd5acbbae43.pdf",
            "news_date": "2025-08-11 16:38:30"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Result of Voting at Annual General Meeting alongwith Scrutinizers Report on Voting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20195c16-7230-4ec2-aa99-9daa7314db71.pdf",
            "news_date": "2025-08-06 22:22:53"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Change in Registered office of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f1957dc-f1c4-4ac9-8cbe-01de38e953d4.pdf",
            "news_date": "2025-08-06 19:22:06"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditors",
            "news_body": "Appointment of Secretarial Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7fc3f88-2237-4e08-a1dc-364836832e07.pdf",
            "news_date": "2025-08-06 19:19:51"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Statutory Auditor/s",
            "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
            "news_body": "Re-appointment of Statutory Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0db7500-291d-4f58-a56b-07f810fce1c6.pdf",
            "news_date": "2025-08-06 19:17:30"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Mr. Nikhil Chopra as CEO and Whole-time Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e3c5d37-c5b7-472e-a3b7-173ba99faf7e.pdf",
            "news_date": "2025-08-06 19:15:50"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Mr. Sumit Bose as Non-Executive Independent Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abdfd8ee-4fd2-49d4-8cfe-4d49090f7883.pdf",
            "news_date": "2025-08-06 19:07:29"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Appointment of Ms. Richa Arora as Non-Executive Independent Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a6df928-aab4-44c5-8db9-3e196955debd.pdf",
            "news_date": "2025-08-06 19:05:42"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Appointment of Mr. Ashwani Kumar Puri as Non-Executive Independent Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95bd38f4-f7e4-41fb-a459-a3a153e84ef8.pdf",
            "news_date": "2025-08-06 19:03:25"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of the Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea0c7ddb-2f37-4b2c-92b1-40fa3226958d.pdf",
            "news_date": "2025-08-06 18:58:35"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Investor / Analyst call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f38cb3b-9801-4241-acae-07aa2736a03e.pdf",
            "news_date": "2025-08-05 19:16:51"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "22eacf3d-74b5-43ba-a4a5-19013bc47107",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d6e7fe-e3dc-438e-82c8-eeea32d233f0.pdf",
            "news_date": "2025-07-31 17:48:30",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d6e7fe-e3dc-438e-82c8-eeea32d233f0.pdf",
            "news_date": "2025-07-31 17:48:30"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement pertaining to financial results for quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8a2e5d7-af2e-46a1-89a1-63139eb7dcef.pdf",
            "news_date": "2025-07-31 17:43:27"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "65fc6b65-07a9-4741-aac3-a98e17fc958b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65369514-828b-4cb8-a706-9779c0eef3cb.pdf",
            "news_date": "2025-07-30 18:10:36",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65369514-828b-4cb8-a706-9779c0eef3cb.pdf",
            "news_date": "2025-07-30 18:10:36"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ffb9a58-de99-466d-a676-368afaf099e6.pdf",
            "news_date": "2025-07-30 18:09:16"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for 1Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30 2025 Accompanied By Limited Review Report.",
            "news_body": "Unaudited standalone and consolidated financial results for the quarter ended on June 30 2025 accompanied by limited review report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4f17821-1c9b-4cd0-a094-5a4eb329f10e.pdf",
            "news_date": "2025-07-30 18:08:01"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investors/analysts call with Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93b53e28-153c-48a8-9a31-8bfa9fa811d2.pdf",
            "news_date": "2025-07-23 18:23:27"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a951dc5-3f3d-42b6-8889-66b17b43799b.pdf",
            "news_date": "2025-07-22 18:30:46"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve the unaudited financial results for the quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69179c2d-ce5f-491b-aff3-2ab06a81f929.pdf",
            "news_date": "2025-07-21 17:14:04"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Letter To Shareholders - Integrated Annual Report",
            "news_body": "Letter to shareholders - Integrated Annual Report 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03e8ad0c-3edc-4e3c-bfa9-91b05d4f77cb.pdf",
            "news_date": "2025-07-17 19:40:19"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edf0e2e0-bf88-419f-879b-e73447f65546.pdf",
            "news_date": "2025-07-17 19:16:10"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=debce1bb-97d1-49cb-87b7-c621d50fa889.pdf",
            "news_date": "2025-07-12 14:39:53"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Draft Letter of Offer",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2E964953-61FC-4B74-AF15-5E6E348DBC95-071659.pdf",
            "news_date": "2025-07-12 07:17:08"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "BRSR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93a29e1b-77f5-46e9-a0cc-d6344a27bde0.pdf",
            "news_date": "2025-07-11 19:50:25"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date",
            "news_body": "Intimation of Record date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c9abe52-f37a-43c9-85bd-e09b60727708.pdf",
            "news_date": "2025-07-11 19:48:57"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report For the Financial Year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd5f6b22-121a-46ee-a934-79d48b8d00a8.pdf",
            "news_date": "2025-07-11 18:50:47"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of Annual General Meeting",
            "news_body": "Notice of Annual General Meeting to be held on August 6 2025 at 1:30 pm.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abdaeee9-672a-417a-a8b0-e6dd25a084bc.pdf",
            "news_date": "2025-07-11 18:40:59"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Change in Director - Appointment of Non-Executive Independent Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30cf332e-8241-426a-b34c-032a44dca91d.pdf",
            "news_date": "2025-07-10 18:25:04"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Detailed Public Statement in connection with the open offer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28fb5fdf-93ce-4d3d-a307-60a173df2d6b.pdf",
            "news_date": "2025-07-04 17:44:00"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "Open Offer",
            "caption": "Updates on Open Offer",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4) 14 (3) and 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended to the eligible Shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6FFDEA5B-3293-4A03-9F94-240FC433EFAA-153518.pdf",
            "news_date": "2025-07-04 15:35:44"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "a53e0cdc-c2d8-4e78-ab1a-f4f207d95ae2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32b9db24-3169-46de-b169-406e7932b44b.pdf",
            "news_date": "2025-06-30 13:30:55",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32b9db24-3169-46de-b169-406e7932b44b.pdf",
            "news_date": "2025-06-30 13:30:55"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Public Announcement",
            "news_body": "NovaaOne Capital Pvt Ltd (\"Manager to the Open Offer\") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13(1) 14 and 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended for the attention of the eligible Shareholders of JB Chemicals & Pharmaceuticals Ltd (\"Target Company\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90ACEEC8-F6A7-4C7F-AD37-3E7E9C004BAA-104520.pdf",
            "news_date": "2025-06-30 10:45:49"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Public Announcement-Open Offer",
            "caption": "Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer",
            "news_body": "Public Announcement of open offer for acquisition of Companys equity shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d338f30a-dd15-4585-b592-546174ede768.pdf",
            "news_date": "2025-06-30 00:51:11"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Disclosure under Regulation 30 - Outcome of the Board meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11c6442d-e33b-4b92-8c0b-e0f0e3d341ee.pdf",
            "news_date": "2025-06-29 20:17:32"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Change in registered office of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb91396-95d5-4177-873b-e20edece710c.pdf",
            "news_date": "2025-06-29 19:58:46"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=969f7f92-c90b-42a8-9eee-36b16eba3fde.pdf",
            "news_date": "2025-06-29 19:46:51"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Mr. Nikhil Chopra Chief Executive Officer- Whole time- Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=096fcaba-a634-4b2b-ad20-4c1ca859c5e0.pdf",
            "news_date": "2025-06-28 19:50:35"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure period",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=581657d7-684f-4177-b986-8f3f3ee70cb5.pdf",
            "news_date": "2025-06-27 23:55:04"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ANDA Approval By US FDA",
            "news_body": "Disclosure made to the stock exchange on June 24 2025 and exchange email dated June 26 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af92bb07-db9b-4c81-9c96-6e41374b9f3a.pdf",
            "news_date": "2025-06-26 17:23:55"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ANDA Approval By US FDA",
            "news_body": "ANDA Approval by US FDA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7b66484-dcfb-4ce1-9283-59f33c862b31.pdf",
            "news_date": "2025-06-24 18:20:59"
        },
        {
            "co_code": 303,
            "bse_code": 506943,
            "isin": "INE572A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement - transfer of shares to IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2240db16-b92b-4c8c-80c0-52129d73dbde.pdf",
            "news_date": "2025-06-18 12:58:52"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "c30674c0-427e-4bcf-87a4-7f0de5d79c83",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=438ccaf4-b65f-4632-9c0b-53dfcb9c0a1c.pdf",
            "news_date": "2025-05-15 16:50:18",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone & Consolidated Financial Results For The Year Ended On March 31 2025",
            "news_body": "Audited Standalone and Consolidated Financial Results for the year ended on March 31 2025",
            "news_id": "579915d9-c266-4c59-91d2-414fccae7e9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7563bee8-e089-47d0-bd87-0ad8ce728004.pdf",
            "news_date": "2025-05-14 19:39:38",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation",
            "news_id": "b883195c-03a6-49fd-b0c4-263a615117d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=806c78c2-67e6-48ca-8ff3-82bd4e00da10.pdf",
            "news_date": "2025-05-14 19:28:22",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "6ad6353b-1439-4fc9-bf7d-a9574ac8cdde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29578ced-9b90-45a6-85ad-7b5da9e3b14b.pdf",
            "news_date": "2025-02-04 18:58:25",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended On December 31 2024",
            "news_body": "Unaudited Financial Results for the quarter ended on December 31 2024",
            "news_id": "f3618d29-b308-4af4-8396-5d8959bf18ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df7b44e6-51fb-4cbd-b386-26f2b05fc0a1.pdf",
            "news_date": "2025-02-04 18:55:05",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Investors/ Analysts call with Company Management",
            "news_id": "6da3ed12-7dd8-4811-aa16-437275cb2f78",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef5cb180-8efb-4e94-aef0-36649656c835.pdf",
            "news_date": "2024-11-07 17:45:07",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "996b7c2d-a5b8-4a72-ae77-d5d9d5d06f5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02427c52-5b7c-4bc1-870c-160be2a58b4d.pdf",
            "news_date": "2024-11-07 12:46:38",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "e83f63fc-2fcc-4291-b5b2-99baaa87db4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d40bafb-7332-4763-84fd-57ff603f09ad.pdf",
            "news_date": "2024-08-09 16:15:31",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "1d1f803d-d52f-4da5-9bb0-41cd57c158eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=011aa108-b813-4029-9aef-c0004d4fb090.pdf",
            "news_date": "2024-08-08 17:09:19",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "163c364c-ffef-4917-84f1-5248778661a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cd35df8-8197-4507-8fad-a46789bb34e3.pdf",
            "news_date": "2024-05-21 16:52:03",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation",
            "news_id": "3aa634cc-f291-4839-a0c1-32fd2e6c3fae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4553606b-eb05-4ab8-ad0b-fe27a0b20468.pdf",
            "news_date": "2024-05-17 18:36:36",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results -31/03/2024",
            "news_body": "Audited Standalone and Consolidated Financial Results -31/03/2024",
            "news_id": "d6eb613b-ed0e-42a5-a5b3-a4e460e776ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74403e6e-f33b-4514-8202-003c81dc235a.pdf",
            "news_date": "2024-05-17 18:24:55",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/ analysts call with Management",
            "news_id": "f2bb0c31-900c-4320-8c89-3477ce919360",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e10547a4-a051-4f67-961a-fc1f29831a25.pdf",
            "news_date": "2024-02-07 18:33:57",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on unaudited financial results for the quarter and nine months ended on December 31, 2023",
            "news_id": "67703855-c87f-47d8-9ab0-be7cbb027519",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbb52fb3-44ae-4f97-97bc-779fa3a06804.pdf",
            "news_date": "2024-02-06 16:17:30",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023",
            "news_body": "Unaudited financial results for the quarter and nine months ended on December 31, 2023",
            "news_id": "13a5dbdb-d896-414f-be89-47641d816646",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7719f5ba-f363-4d1b-b095-e3282cee2dc7.pdf",
            "news_date": "2024-02-06 16:00:16",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "00ae600a-5960-4784-b557-c879c7aeb5c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1f5db76-0fce-488a-ac09-df0e8e93884d.pdf",
            "news_date": "2023-12-22 22:38:05",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "568f71d5-0d68-4ca7-90ac-d4c81bc87d74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10ce0707-700c-4a8f-8fc4-76826753dc6e.pdf",
            "news_date": "2023-12-19 12:50:34",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "09245d71-546d-48c1-bc11-2526ea7a6e56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bd36f22-a54d-463a-850e-037eb4de89c3.pdf",
            "news_date": "2023-11-08 18:42:18",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "5222a530-da21-4739-a7be-e6aebccc0c6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67970406-8908-48a8-a58e-d08e98779698.pdf",
            "news_date": "2023-11-07 15:50:53",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors",
            "news_body": "Unaudited financial results for the quarter and half year ended on September 30, 2023 accompanied by limited review report",
            "news_id": "8a5fc7a9-07f7-4c87-8af4-2ea9f46fc735",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aac50d59-9636-40f9-a688-ae8c634003fb.pdf",
            "news_date": "2023-11-07 15:29:14",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "16275956-e55c-40a4-ab67-a198a3bc5061",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3baeeea-fd57-4cbd-b1d8-c584e430e081.pdf",
            "news_date": "2023-08-10 18:53:30",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "3a1da197-2937-4a9f-b6b5-e3ee94aae842",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5b618a-6e00-4f92-9303-d1d010dd26ac.pdf",
            "news_date": "2023-08-09 16:01:44",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Investors/Analysts call",
            "news_id": "b6e989f8-fabc-422b-ba9f-97c5844fd70d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7963d883-0d72-449a-aa5f-f5c0734c7b8b.pdf",
            "news_date": "2023-05-30 11:54:42",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/analysts call with Management",
            "news_id": "9c0fe054-b977-4f33-8fae-cfcb08ac0fdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4960058-510e-4909-aa10-0636bf07b25b.pdf",
            "news_date": "2023-05-25 17:56:32",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "2cab3b77-bc50-4f50-94bd-ecab96586c09",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0adb8e27-1317-482d-a620-cabbe4efaba9.pdf",
            "news_date": "2023-05-24 16:57:18",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board meeting- Audited standalone and consolidate  financial results for the year ended on March 31, 2023",
            "news_id": "35a72113-8a76-451a-af3b-c08d0de0387d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14ba8b38-1603-4f51-a260-abdfcbc32c04.pdf",
            "news_date": "2023-05-24 16:29:16",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Investors/Analysts call",
            "news_id": "1eeac3a7-16a9-4fc8-8140-775680b4cccf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cc90ead-d36e-41e2-a1be-b23c2839e511.pdf",
            "news_date": "2023-02-13 17:15:41",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 -  Audio recording of Investors/analysts call with Management",
            "news_id": "5a8d0c87-8248-4ebf-9fce-87f182e392f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0df0ee6-a141-4bb2-a46b-06837a2b377e.pdf",
            "news_date": "2023-02-09 21:22:11",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Enclosed please find the presentation the Company proposes to make to investors/analysts on performance of the Company for the quarter ended on December 31, 2022.",
            "news_id": "e717053d-f57e-4e2b-a5b0-95975d0f2ee7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81e6c8b4-1fc7-4e61-9f9f-8ea90fdee279.pdf",
            "news_date": "2023-02-08 18:43:41",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended December 31, 2022",
            "news_body": "Unaudited Financial Results for the quarter ended December 31, 2022",
            "news_id": "147f0e62-f596-4a44-b8e3-d3eb80232be4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c82a3cc-32e9-43a9-88e1-e42fde11ed4b.pdf",
            "news_date": "2023-02-08 18:31:46",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at JP Morgan Healthcare Conference, SFO US",
            "news_id": "b587aa5f-9953-403d-b999-d1d10d0a90a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83ba8a10-2bd6-4714-b902-479f272fb237.pdf",
            "news_date": "2023-01-10 15:39:36",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Conference Call which was scheduled for Investors and Analysts on November 14, 2022 at 3.30 p.m. IST in relation to results and developments for the second quarter ended on September 30, 2022.",
            "news_id": "c0390fa0-41f3-4cd3-bd02-f41557fb7325",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc27f9a1-4d46-4ac2-ad51-36976fdeb6c6.pdf",
            "news_date": "2022-11-18 14:18:16",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Investors/Analysts Call With Management",
            "news_body": "Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/analysts call with Management",
            "news_id": "2515a071-6893-450f-8b0b-b939dc28da14",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a785852-8133-4f21-af82-01532129290c.pdf",
            "news_date": "2022-11-14 18:45:28",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "investors/analysts presentation the Company proposes to on performance of the Company for the quarter ended on September 30, 2022.",
            "news_id": "024a68a3-9846-44ae-a198-830eaf0ae143",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ace8963-f39f-400b-8b61-49e697c0c101.pdf",
            "news_date": "2022-11-11 18:34:31",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended September 30, 2022",
            "news_body": "In compliance with Regulation 30(2) and Regulation 33(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015, enclosed please find: <BR> <BR> 1. Unaudited standalone financial results for the quarter ended on September 30, 2022 accompanied by limited review report. <BR> 2. Unaudited consolidated financial results for the quarter ended on September 30, 2022 accompanied by limited review report. <BR> <BR> These financial results have been approved and taken on record by the Board of Directors at its meeting held today, which commenced at 4.18 p.m. and concluded at 6.12 p.m.<BR>",
            "news_id": "a39848fd-234b-405f-9c65-5bb7fed32a56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c2f95cd-acca-4731-b792-0d0afda57207.pdf",
            "news_date": "2022-11-11 18:28:26",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/Analysts call with Management",
            "news_id": "692c46d4-58ed-44f5-9e00-ea9634302197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e24b532-72ac-44a2-a55a-a7ae4eeb5318.pdf",
            "news_date": "2022-08-05 17:24:57",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "1e0f7120-97d1-4c7c-a35f-3302c94b45ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53cbb39-c7c2-4121-9681-7212ce0006e6.pdf",
            "news_date": "2022-08-04 19:19:27",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended June 30, 2022<BR>",
            "news_id": "bb5adca7-bc09-4cc7-adbd-add892070825",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f6d1d05-697a-4b20-9630-af5023643e30.pdf",
            "news_date": "2022-08-04 19:05:10",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Investors/Analysts Meet",
            "news_id": "e50a99ce-5e21-47d3-884a-1b02c5aa67f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62aed8bb-2cd2-497c-8f02-696594e42631.pdf",
            "news_date": "2022-05-31 17:56:49",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Investors/Analysts Meet",
            "news_body": "Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/Analysts Meet",
            "news_id": "5f4f9567-7722-4ad4-9547-a707f5cb1179",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14c9489a-bc65-46f5-bc22-542e205d5176.pdf",
            "news_date": "2022-05-28 15:54:56",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on financial results for the quarter and year ended on March 31, 2022.",
            "news_id": "3694600f-6ddf-4092-8ad6-e26b6fe1c17a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07e15db6-4a59-4460-8c23-b84a00cfc380.pdf",
            "news_date": "2022-05-27 11:22:32",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors",
            "news_body": "1. Audited standalone financial results for the year ended on March 31, 2022 accompanied by Auditors' Report. <BR> 2. Audited consolidated financial results for the year ended on March 31, 2022 accompanied by Auditors' Report. <BR> 3. Declaration of Unmodified opinion",
            "news_id": "39b47eb1-37d7-4172-88b2-d536c4fb3424",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=073c86d2-2098-41db-900a-bd6628560501.pdf",
            "news_date": "2022-05-26 15:33:38",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings conference call Transcript and Audio recording",
            "news_id": "3ba90688-3776-415c-85f7-fc3aeff84e72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba50ac71-7c6d-415c-b671-ea05d457bbe0.pdf",
            "news_date": "2022-02-18 16:45:29",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended December 31, 2021",
            "news_body": "Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended December 31, 2021",
            "news_id": "6159363c-2ebd-4453-a686-bbd9b1b30e29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dcc3f43-c440-4419-9e18-ea848a83769d.pdf",
            "news_date": "2022-02-14 18:23:56",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investors/analysts call Transcript and Audio recording",
            "news_id": "ae5d7e7e-2665-4fb7-aba9-af4010d4c196",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d377ade8-5ed9-4e9e-97c9-8fa62a658aa8.pdf",
            "news_date": "2022-01-31 17:08:31",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings conference call",
            "news_id": "3a1761fe-1fff-4256-8d8e-23f5b0f8bd8e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06a9c70c-e79e-4e3b-9b3e-c542f9f6fbe4.pdf",
            "news_date": "2021-11-17 15:15:00",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "b2b7ab4b-2514-4706-9874-14b17c3bf985",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cecf5169-4c50-49cb-afbf-838249f02aad.pdf",
            "news_date": "2021-11-11 18:56:30",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended September 30, 2021",
            "news_body": "Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended September 30, 2021",
            "news_id": "b26a3c65-8df8-4c77-bed0-98f071884cc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61c4df70-53d9-4a36-abaa-0a552891d968.pdf",
            "news_date": "2021-11-11 18:43:50",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript - Q1 FY 22",
            "news_id": "ec5e609f-5a83-4201-9de9-a5ba2b2f6653",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04306bb6-6c0f-46fb-b2ec-a8f56be468bb.pdf",
            "news_date": "2021-08-19 14:54:12",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Conference Call",
            "news_body": "Audio recording of the Earnings Conference Call - Q1 FY 2021-22",
            "news_id": "da061ec0-4f86-4a35-acb9-5149a7d67d2e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01ecb4b2-96fd-4767-b079-d4ef7aa95356.pdf",
            "news_date": "2021-08-14 14:46:58",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "a02b8c1f-fcac-4328-bd0c-1b4c4a9fe819",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9babebbb-94af-4a48-9c7a-1b48fb27a673.pdf",
            "news_date": "2021-08-12 19:17:40",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2021",
            "news_id": "966cd59f-3303-4f2b-abf5-7e79d4de1641",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=216b9a5d-159c-40f9-9b25-77633d615126.pdf",
            "news_date": "2021-08-12 19:06:28",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended June 30, 2021",
            "news_id": "d7cbfe04-cac2-4333-b84e-c738eca8cb74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f7bc6be-5c92-4aff-8ccc-68817add7a50.pdf",
            "news_date": "2021-08-12 19:03:21",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JBCHEPHARM",
            "disp": "J B Chemicals and Pharmaceuticals",
            "bse_code": 506943,
            "isin": "INE572A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results",
            "news_body": "Audited standalone and consolidated financial results for the year ended on March 31, 2021",
            "news_id": "f92888e8-fa76-4419-ac0a-5f141ea1685b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cf0e6be-ee5d-4d55-bed6-86be5eeb0659.pdf",
            "news_date": "2021-06-14 21:13:55",
            "seo": "jb-chemicals-pharmaceuticals-ltd",
            "ltp": 1894.8,
            "ch": -28.299999999999955,
            "pch": -1.4715823410119055,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1726,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}